{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:34:06Z","timestamp":1789785246013,"version":"4.0.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Institute for Communicable Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:label\/>\n                  <jats:p>Histoplasma antigen detection in urine is a rapid diagnostic method for disseminated histoplasmosis, although cross-reactivity has been reported in specimens from patients with other thermally dimorphic fungal infections. We tested urine specimens, from persons with suspected invasive fungal infections, using a commercial monoclonal antibody Histoplasma enzyme immunoassay (EIA) at a South African national mycology reference laboratory from August 2014 through December 2018. Corresponding fungal culture and histopathology results were obtained from an electronic laboratory information system. In some cases, cultured fungal isolates were sent with the urine specimen for species-level identification by phenotypic and molecular methods. Cross-reactivity was confirmed using culture filtrates of several fungal pathogens. Of 212 referred cases, 41 (19%) were excluded since they had no recorded clinical history (n\u00a0=\u00a01), alternative diagnoses were confirmed (n\u00a0=\u00a02), or no fungal culture or histopathology results (n\u00a0=\u00a038). Eighty-seven of 212 (41%) had laboratory evidence of an invasive fungal disease, while 84 (40%) did not. Of the 87 cases, 37 (43%) were culture-confirmed mycoses: emergomycosis (n\u00a0=\u00a018), histoplasmosis (n\u00a0=\u00a08), sporotrichosis (n\u00a0=\u00a06), cryptococcosis (n\u00a0=\u00a02), talaromycosis (n\u00a0=\u00a01), and other fungi isolated (n\u00a0=\u00a02). The sensitivity and specificity of the EIA were calculated for two groups: culture-confirmed (n\u00a0=\u00a037) and histology-confirmed invasive fungal disease (n\u00a0=\u00a050). The sensitivity and specificity of the EIA for diagnosis of histoplasmosis compared to culture were 88% (7\/8, 95%CI 47-100%) and 72% (21\/29, 95%CI 53-87%), respectively, and for diagnosis of emergomycosis\/histoplasmosis compared to histology was 83% (29\/35, 95%CI 66-93%) and 93% (14\/15, 95%CI 68-100%), respectively. Cross-reactions occurred in urine specimens of patients with Emergomyces africanus infection and in culture filtrates of E. africanus, T. marneffei and Blastomyces species. A commercial Histoplasma EIA had satisfactory accuracy for diagnosis of culture-confirmed histoplasmosis, but cross-reacted in urine specimens from patients with invasive disease caused by the closely-related pathogen, E. africanus and in culture filtrates of E. africanus and other related fungi.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Lay summary<\/jats:title>\n                  <jats:p>Emergomyces africanus and Histoplasma capsulatum are fungi that cause a multi-system disease among HIV-seropositive persons with a low CD4 cell count. Handling live cultures of these fungi to confirm a diagnosis requires specialized laboratory equipment and infrastructure which is infrequently accessible in low-resource settings. The features of the two diseases (i.e., disseminated histoplasmosis and emergomycosis) may be indistinguishable when infected tissue is prepared, stained, and examined under a microscope. Enzyme immunoassays (EIA) have been developed as rapid diagnostic tools for the detection of a cell wall component of H. capsulatum in urine specimens, although cross-reactions have been reported in specimens from patients with other fungal infections. We evaluated the accuracy of a commercial Histoplasma EIA to diagnose histoplasmosis and to assess cross-reactions in urine specimens from persons with emergomycosis and in cultures of E. africanus and related fungi. We report a sensitivity and specificity of 88% (95%CI 47-100%) and 72% (95%CI 53-87%) for diagnosis of histoplasmosis compared to culture and 83% (95%CI 66-93%) and 93% (95%CI 68-100%) for diagnosis of either histoplasmosis\/emergomycosis compared to a diagnosis made by microscopic examination of infected tissue. The assay cross-reacted in urine specimens from patients with emergomycosis and in culture filtrates of related fungi. Although the EIA cross-reacted with other related fungi, this test can decrease the time to diagnosis and facilitate early treatment of emergomycosis and histoplasmosis in South Africa.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mmy\/myaa100","type":"journal-article","created":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T01:07:26Z","timestamp":1607735246000},"page":"672-682","source":"Crossref","is-referenced-by-count":23,"title":["Cross-reactivity of a <i>Histoplasma capsulatum<\/i> antigen enzyme immunoassay in urine specimens from persons with emergomycosis in South Africa"],"prefix":"10.1093","volume":"59","author":[{"given":"Tsidiso G","family":"Maphanga","sequence":"first","affiliation":[{"name":"National Institute for Communicable Diseases (Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), a Division of the National Health Laboratory Service, Johannesburg, South Africa"},{"name":"Department of Medical Microbiology, University of the Free State, Bloemfontein, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serisha D","family":"Naicker","sequence":"additional","affiliation":[{"name":"National Institute for Communicable Diseases (Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), a Division of the National Health Laboratory Service, Johannesburg, South Africa"},{"name":"School of Pathology, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz L","family":"G\u00f3mez","sequence":"additional","affiliation":[{"name":"School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabatho","family":"Mhlanga","sequence":"additional","affiliation":[{"name":"National Institute for Communicable Diseases (Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), a Division of the National Health Laboratory Service, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth S","family":"Mpembe","sequence":"additional","affiliation":[{"name":"National Institute for Communicable Diseases (Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), a Division of the National Health Laboratory Service, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7522-0281","authenticated-orcid":false,"given":"Ilan S","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Bamford","sequence":"additional","affiliation":[{"name":"National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa"},{"name":"Division of Medical Microbiology, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Nel","sequence":"additional","affiliation":[{"name":"School of Pathology, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7869-9462","authenticated-orcid":false,"given":"Nelesh P","family":"Govender","sequence":"additional","affiliation":[{"name":"National Institute for Communicable Diseases (Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), a Division of the National Health Laboratory Service, Johannesburg, South Africa"},{"name":"School of Pathology, University of the Witwatersrand, Johannesburg, South Africa"},{"name":"Division of Medical Microbiology, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"2021070523532785600_bib1","doi-asserted-by":"crossref","first-page":"ofx186","DOI":"10.1093\/ofid\/ofx186","article-title":"AIDS-related endemic mycoses in Western Cape, South Africa, and clinical mimics: A cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions","volume":"4","author":"Schwartz","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2021070523532785600_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/myc.12601","article-title":"Novel taxa of thermally dimorphic systematic pathogens in the Ajellomycetaceae (Onygenales)","volume":"60","author":"Dukik","year":"2017","journal-title":"Mycoses"},{"key":"2021070523532785600_bib3","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1128\/JCM.02524-16","article-title":"In vitro antifungal susceptibility of yeast and mold phases of isolates of dimorphic fungal pathogen Emergomyces africanus (Formerly Emmonsia sp,) from HIV-infected South African Patients","volume":"55","author":"Maphanga","year":"2017","journal-title":"J Clinl Microbiol"},{"key":"2021070523532785600_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000495405","article-title":"Emergomycosis (Emergomyces africanus) in advanced HIV Disease","volume":"6","author":"Govender","year":"2019","journal-title":"Dermatopathology"},{"key":"2021070523532785600_bib5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/civ439","article-title":"Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: A Retrospective case series","volume":"61","author":"Schwartz","year":"2015","journal-title":"Clin Infect Di"},{"key":"2021070523532785600_bib6","doi-asserted-by":"crossref","first-page":"e1007977","DOI":"10.1371\/journal.ppat.1007977","article-title":"Emergomyces: The global rise of new dimorphic fungal pathogens","volume":"15","author":"Schwartz","year":"2019","journal-title":"PLoS Pathog"},{"key":"2021070523532785600_bib7","doi-asserted-by":"crossref","first-page":"e0006802","DOI":"10.1371\/journal.pntd.0006802","article-title":"Histoplasma capsulatum antigen detection tests as an essential diagnostic tool for patients with advanced HIV disease in low and middle income countries: A systematic review of diagnostic accuracy studies","volume":"12","author":"Nacher","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2021070523532785600_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/jof5030076","article-title":"Diagnosis of progressive disseminated histoplasmosis in advanced HIV: A meta-analysis of assay analytical performance","volume":"5","author":"C\u00e1ceres","year":"2019","journal-title":"J Fungi"},{"key":"2021070523532785600_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-3062.2006.00151.x","article-title":"Elimination of false-positive Histoplasma antigenemia caused by human anti-rabbit antibodies in the second-generation Histoplasma antigen assay","volume":"8","author":"Wheat","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"2021070523532785600_bib10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1128\/CVI.00071-07","article-title":"Detection of Histoplasma antigen by a Quantitative Enzyme Immunoassay","volume":"14","author":"Connolly","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"2021070523532785600_bib11","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1128\/JCM.02298-13","article-title":"Evaluation of commercially available reagents for the diagnosis of histoplasmosis infection in immunocompromised patients","volume":"12","author":"Zhang","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2021070523532785600_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/CVI.00035-07","article-title":"Evaluation of the IMMY ALPHA Histoplasma antigen enzyme immunoassay for diagnosis of histoplasmosis marked by antigenuria","volume":"14","author":"LeMonte","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"2021070523532785600_bib13","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1128\/JCM.01868-13","article-title":"Evaluation of an enzyme immunoassay for detection of Histoplasma capsulatum antigen from urine specimens","volume":"51","author":"Theel","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2021070523532785600_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/mmy\/myv062","article-title":"Evaluation of two new enzyme immunoassay reagents for diagnosis of histoplasmosis in a cohort of clinically characterized patients","volume":"53","author":"Zhang","year":"2015","journal-title":"Medical Mycol"},{"key":"2021070523532785600_bib15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/JCM.03175-14","article-title":"Re-evaluation of commercial reagents for detection of Histoplasma capsulatum Antigen in Urine","volume":"53","author":"Theel","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2021070523532785600_bib16","doi-asserted-by":"crossref","first-page":"pii: e01959\u201317","DOI":"10.1128\/JCM.01959-17","article-title":"Multicenter validation of commercial antigenuria reagents to diagnose progressive disseminated histoplasmosis in people living with HIV\/AIDS in two Latin American countries","volume":"56","author":"C\u00e1ceres","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2021070523532785600_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12281-018-0308-y","article-title":"Emergomyces: a new genus of dimorphic fungal pathogens causing disseminated disease among immunocompromised persons globally","volume":"12","author":"Schwartz","year":"2018","journal-title":"Curr Fungal Infect Rep"},{"key":"2021070523532785600_bib18","article-title":"Emergomycosis (formely disseminated emmonsiosis)","volume-title":"Essentials of Human Mycosis","author":"Govender","year":"2018"},{"key":"2021070523532785600_bib19","volume-title":"Mid-Year Population Estimates 2019. Statistical Release P0302","author":"Statistics South Africa","year":"2019"},{"key":"2021070523532785600_bib20","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/cid\/ciy045","article-title":"Persistent high burden of advanced HIV disease among patients seeking care in South Africa's national HIV program: Data from a nationawide laboratory cohort","volume":"66","author":"Carmona","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2021070523532785600_bib21","doi-asserted-by":"crossref","first-page":"e1002468","DOI":"10.1371\/journal.pmed.1002468","article-title":"Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study","volume":"14","author":"Johnson","year":"2017","journal-title":"PLoS Med"},{"key":"2021070523532785600_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.7196\/SAMJ.2019.v109i11.13718","article-title":"The estimated burden of fungal disease in South Africa","volume":"109","author":"Schwartz","year":"2019","journal-title":"S Afr Med J"},{"key":"2021070523532785600_bib23","first-page":"315","article-title":"Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics","volume-title":"PCR Protocols: A Guide to Methods and Applications","author":"White","year":"1990"},{"key":"2021070523532785600_bib24","doi-asserted-by":"crossref","first-page":"e2281","DOI":"10.1371\/journal.pntd.0002281","article-title":"Phylogenetic analysis reveals a high prevalence of Sporothrix brasiliensis in feline sporotrichosis outbreak","volume":"7","author":"Rodrigues","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2021070523532785600_bib25","first-page":"119","article-title":"Histoplasmosis in HIV-infected patients: a review of new developments and remaining gaps","volume":"1","author":"Adenis","year":"2014","journal-title":"Curr Trop Med Rep"},{"key":"2021070523532785600_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tim.2003.08.007","article-title":"Current diagnosis of histoplasmosis","volume":"11","author":"Wheat","year":"2003","journal-title":"Trends Microbiol"},{"key":"2021070523532785600_bib27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00006454-199409000-00010","article-title":"The Histoplasma capsulatum antigen assay in disseminated histoplasmosis in children","volume":"13","author":"Fojtasek","year":"1994","journal-title":"Pediatr Infect Dis"},{"key":"2021070523532785600_bib28","author":"World Health Organization"},{"key":"2021070523532785600_bib29","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1128\/jcm.35.10.2618-2622.1997","article-title":"Development of a novel antigen detection test for histoplsmosis","volume":"35","author":"Gomez","year":"1997","journal-title":"J Clin Microbiol"},{"key":"2021070523532785600_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/AAC.46.1.248-250.2002","article-title":"Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS","volume":"46","author":"Wheat","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2021070523532785600_bib31","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/CVI.05017-11","article-title":"Cross-reactivity in the Histoplasma antigen enzyme immunoassay caused by sporotrichosis","volume":"18","author":"Assi","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"2021070523532785600_bib32","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1215460","article-title":"A dimorphic fungus causing disseminated infection in South Africa","volume":"369","author":"Kenyon","year":"2013","journal-title":"N Engl J Med"},{"key":"2021070523532785600_bib33","doi-asserted-by":"crossref","first-page":"e01661","DOI":"10.1128\/JCM.01661-19","article-title":"Human blastomycosis in South Africa caused by Blastomyces percursus and Blastomyces emzantsi sp. nov., 1967\u20132014","volume":"58","author":"Maphanga","year":"2020","journal-title":"J Clin Micro"},{"key":"2021070523532785600_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13225-018-0403-y","article-title":"Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis","volume":"90","author":"Jiang","year":"2018","journal-title":"Fungal Divers"},{"key":"2021070523532785600_bib35","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1128\/AAC.02973-14","article-title":"In vitro antifungal susceptibility profile and correlation of mycelial and yeast forms of molecularly characterized Histoplasma capsulatum strains from India","volume":"58","author":"Kathuria","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/7\/672\/38670753\/myaa100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/7\/672\/38670753\/myaa100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T19:54:40Z","timestamp":1625514880000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/59\/7\/672\/6039540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,12,16]]},"published-print":{"date-parts":[[2021,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaa100","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7]]},"published":{"date-parts":[[2020,12,16]]}}}